Bausch Health Companies | VRX - Stock


Bausch Health Companies reported $1.63B in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Amgen USD 6.19B 39M Mar/2026
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Aurora Cannabis CAD 230.56M 8.6M Dec/2025
Bausch Health Companies USD 1.63B 31M Dec/2025
Biogen USD 1.95B 219.1M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Canopy Growth CAD 105.56M 3.18M Dec/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Danaher USD 2.61B 119M Mar/2026
Drreddys Laboratories INR 79.01B 3.41B Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 159.13M 4.46M Mar/2026
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026
Zoetis USD 2.55B 120M Mar/2026